Note: Pocket reference with interaction information and patient education recommendations.

Note: One page tip sheet.

Note: There are an estimated 250,000 people living in the United States with HIV/hepatitis C (HCV) coinfection, yet less than a third of these individuals "are deemed eligible for HCV treatment, and under 10% actually receive treatment.." "Without HCV treatment, increasing numbers of HIV-infected patients will die either from end-stage liver disease or from HIV-related complications resulting from the inability to use antiretroviral agents" because of liver damage.

This is the first of a two-part series. Part 1 provides a medical, psychiatric, psychosocial, and neuropsychological overview of HIV/HCV coinfection, the process of determining eligibility for HCV treatment, and the important role mental health clinicians play in assessing eligibility and intervening with clients who elect to receive treatment for HCV.

Note: This guide for clinicians provides an overview of latent tuberculosis infection in the context of HIV; toxicity monitoring; identification and management of hepatotoxicity; strategies to limit toxicity; and more.

Note: This brochure offers tips for people living with HIV/AIDS who are planning travel to Mexico and Latin America, along with local contact information for HIV/AIDS programs in Latin American countries.

DATE: Monday, April 19, 2010
TIME: 6:30PM - 8:30PM PST
LOCATION: Nick & Stef's Steakhouse (dinner will be served)
330 South Hope Street, Los Angeles, CA 90071 (213) 680-0330
GUEST EDUCATOR: Ronald E. Jefferson, MD; Physician Specialist, OASIS Clinic, Los Angeles, CA

Note: This course is designed for physicians treating HIV and AIDS patients. Registered nurses, nurse practitioners and pharmacists are also welcome to participate and receive continuing education credit (details below).

Upon completion of this CME/CE activity, participants should be able to:

	Explain the current recommendations on when to initiate antiretroviral therapy defined by the Department of Health and Human Services (DHHS) guidelines.
	Describe the efficacy and safety data on key clinical trials on preferred initial antiretroviral regimens recommended by the DHHS guidelines.
	Explain what constitutes treatment failure and review treatment considerations when a change in therapy is warranted.

TO REGISTER: www.simplyspeakinghiv.com
Click on "Event Registration" and enter event code: 23000164
Click on "Begin Registration"
*There is no charge for this event.*

Please contact Elissa Bradley at cduelissa@gmail.com for information on other upcoming Pacific AIDS Education Center trainings and conferences.

Note: The 2010 Ryan White HIV/AIDS Program Grantee Meeting and Clinical Update will take place August 23-26 in Washington, DC. The conference Web site is now live and open for registration and abstract submission. Web site features include detailed information on requirements for abstracts, with a key focus on sharing of how-to information with your Ryan White colleagues.

Abstracts for both workshops and posters are due May 12.

Visit the Web site at: http://www.ryanwhite2010.com

	April 16, 2010: Oral Health, HIV/AIDS and Nutrition: A Clinical Update
	April 20, 2010: Session II: HIV/AIDS andHepatitisPolicies and Communities of Color:Current Challenges; Positive Solutions
	April 23, 2010: Are Your Electronic Patient Data Back Up Procedures Putting Your Organization at Risk?

For the complete list and more information, please visit: www.nmaetc.org